Proteome Sciences plc (LON:PRM – Get Free Report) shares reached a new 52-week low during trading on Wednesday . The company traded as low as GBX 2.30 ($0.03) and last traded at GBX 2.40 ($0.03), with a volume of 1232701 shares changing hands. The stock had previously closed at GBX 2.76 ($0.04).
Proteome Sciences Stock Performance
The business has a 50-day simple moving average of GBX 2.79 and a 200 day simple moving average of GBX 3.28. The firm has a market cap of £8.29 million, a P/E ratio of -264.00 and a beta of 0.07.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
See Also
- Five stocks we like better than Proteome Sciences
- Financial Services Stocks Investing
- The Latest 13F Filings Are In: See Where Big Money Is Flowing
- 3 Warren Buffett Stocks to Buy Now
- 3 Penny Stocks Ready to Break Out in 2025
- How to Use the MarketBeat Stock Screener
- FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.